Skip to main content
Premium Trial:

Request an Annual Quote

Algonomics Nets $2.7M After Second Closing of VC Round

NEW YORK (GenomeWeb News) — Algonomics has taken in €500,000 ($670,000) in a second closing of a financing round to net a total of €2 million ($2.7 million), the company said today.
The immunoprofiling company plans to use the funding to continue developing an in vitro screening platform, called Epibase, to complement its existing screening products and services.
Algonomics, based in Ghent, Belgium, said Epibase screens and optimizes biotherapeutics, including therapeutic antibodies, biosimilars, and vaccines.
"This investment allows a significant growth of our in vitro assays,” Algonomics CEO Ignace Lasters said in a statement. “Moreover, it allows the further evaluation of novel technologies to address all aspects of immunogenicity.”
The company said the second closing was subscribed by Fortis Private Equity and KBC Private Equity, and the funding round was led by Baekeland II fund and subscribed by Gemma Frisius Funds, Flanders Institute for Biotechnology, and TrustCapital.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.